Clinical Trial Update: Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance

View source ↗

Summary

A clinical trial update examining switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients with antiviral resistanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Vemlidy (tenofovir alafenamide)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Yonsei University | Conditions: Hepatitis B, Antiviral Drug Adverse Reaction | Status: UNKNOWN